Title:
ANTICANCER AGENT AND CONCOMITANT DRUG WITH RADIATION IN CHEMORADIOTHERAPY, CONTAINING GOLD COMPLEX
Document Type and Number:
Japanese Patent JP2021017451
Kind Code:
A
Abstract:
To provide an anticancer agent or a concomitant drug with radiation in chemoradiotherapy containing a gold complex with an amino acid derivative as a ligand, and a novel gold complex that can be used in the anticancer agent or the concomitant drug with radiation in chemoradiotherapy.SOLUTION: An anticancer agent or a concomitant drug with radiation in chemoradiotherapy, containing a gold complex represented by the formula (1): L1-S-Au-(L2)m (1) (where L1 is an amino acid derivative, L2 is a heterocycle having -SH coordinated to Au shown in the formula (1), optionally having a further substituent, m is 0 or 1).SELECTED DRAWING: None
Inventors:
KASHIWAKURA IKURO
YOSHINO HIRONORI
HONMA HIDEO
CHRISTOPHER ERNEST JOHN CORDONIER
SANO NAOYUKI
YOSHINO HIRONORI
HONMA HIDEO
CHRISTOPHER ERNEST JOHN CORDONIER
SANO NAOYUKI
Application Number:
JP2020126874A
Publication Date:
February 15, 2021
Filing Date:
July 27, 2020
Export Citation:
Assignee:
LLC ELM RODO EISEI KAGAKU
KANTO GAKUIN
KANTO GAKUIN
International Classes:
A61K31/555; A61K47/32; A61P35/00; C07D249/12; C07D257/04; C07D285/135; C07F1/12; C12Q1/02
Attorney, Agent or Firm:
Masayuki Masabayashi
Yuichi Niiyama
Yuichi Niiyama